Nothing Special   »   [go: up one dir, main page]

AR087209A2 - Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico - Google Patents

Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico

Info

Publication number
AR087209A2
AR087209A2 ARP120102582A ARP120102582A AR087209A2 AR 087209 A2 AR087209 A2 AR 087209A2 AR P120102582 A ARP120102582 A AR P120102582A AR P120102582 A ARP120102582 A AR P120102582A AR 087209 A2 AR087209 A2 AR 087209A2
Authority
AR
Argentina
Prior art keywords
methyl
bencimidazol
preparation
bifenil
ilmetil
Prior art date
Application number
ARP120102582A
Other languages
English (en)
Inventor
Norbert Hauel
Rolf Dach
Helmut Heitger
Oliver Meyer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33016100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR087209(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR087209A2 publication Critical patent/AR087209A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Reivindicación 1: Procedimiento para la preparación de telmisartan, caracterizado porque (a) 2-n-propil-4-metil-6-(1’-metilbencimidazol-2’-il)-bencimidazol de fórmula (1) se hace reaccionar con un compuesto de la fórmula general (2) en la cual Z representa un grupo lábil, y el compuesto así obtenido, en caso deseado, se somete a una elaboración, (b) el grupo ciano del compuesto, así obtenido, 2-ciano-4’-[2’’-n-propil-4’’-metil-6’’-(1’’’-metilbencimidazol-2’’’-il)-bencimidazol-1’’-il-metil]bifenilo de fórmula (3) se transforma a continuación por hidrólisis en la función ácido, y el telmisartan, así obtenido, se transforma durante la elaboración, en caso deseado, en el hidrocloruro.
ARP120102582A 2003-03-31 2012-07-17 Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico AR087209A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10314702A DE10314702A1 (de) 2003-03-31 2003-03-31 Verfahren zur Herstellung von Telmisartan

Publications (1)

Publication Number Publication Date
AR087209A2 true AR087209A2 (es) 2014-02-26

Family

ID=33016100

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP040101066A AR043794A1 (es) 2003-03-31 2004-03-31 Procedimiento para la preparacion de acido 4' - [2 - n - propil-4-metil-6- (1-metil-bencimidazol-2-il) bencimidazol-1-ilmetil] - bifenil- 2 - carboxilico
ARP120102582A AR087209A2 (es) 2003-03-31 2012-07-17 Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP040101066A AR043794A1 (es) 2003-03-31 2004-03-31 Procedimiento para la preparacion de acido 4' - [2 - n - propil-4-metil-6- (1-metil-bencimidazol-2-il) bencimidazol-1-ilmetil] - bifenil- 2 - carboxilico

Country Status (26)

Country Link
US (2) US7193089B2 (es)
EP (2) EP2322511B1 (es)
JP (1) JP5160740B2 (es)
KR (1) KR101096499B1 (es)
CN (1) CN100418953C (es)
AR (2) AR043794A1 (es)
AT (1) ATE515500T1 (es)
AU (1) AU2004226239B2 (es)
BR (1) BRPI0408861A (es)
CA (1) CA2520714C (es)
CL (1) CL2004000687A1 (es)
CY (2) CY1112020T1 (es)
DE (1) DE10314702A1 (es)
DK (2) DK2322511T3 (es)
ES (2) ES2432647T3 (es)
IL (1) IL171145A (es)
MX (1) MXPA05009529A (es)
NZ (1) NZ543244A (es)
PE (1) PE20050390A1 (es)
PL (2) PL2322511T3 (es)
PT (2) PT2322511E (es)
RU (1) RU2430092C2 (es)
SI (2) SI1611108T1 (es)
TW (1) TWI335916B (es)
UY (1) UY28246A1 (es)
WO (1) WO2004087676A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
KR20070061583A (ko) * 2004-10-15 2007-06-13 테바 파마슈티컬 인더스트리즈 리미티드 텔미사르탄의 제조 방법
US7943781B2 (en) 2004-10-18 2011-05-17 Dr. Reddy's Laboratories Limited Process for preparing telmisartan
EP1871764A1 (en) * 2005-04-01 2008-01-02 LEK Pharmaceuticals D.D. A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists
ITMI20050801A1 (it) * 2005-05-03 2006-11-04 Dipharma Spa Procedimento per la preparazione di telmisartan
WO2006136916A2 (en) * 2005-06-20 2006-12-28 Glenmark Pharmaceuticals Limited Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
US20060264491A1 (en) * 2006-06-08 2006-11-23 Chemagis Ltd. Telmisartan production process
CN101172968B (zh) * 2006-11-01 2010-05-12 浙江天宇药业有限公司 2-正丙基-4甲基-6-(甲基苯并咪唑-2-基)苯并咪唑盐及其制备方法
CN101743228B (zh) * 2007-07-03 2014-01-29 新梅斯托克尔卡托瓦纳兹德拉韦尔公司 替米沙坦的制备方法
CZ302272B6 (cs) 2007-07-09 2011-01-19 Zentiva, A. S. Zpusob výroby 4´-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-karboxylové kyseliny (telmisartanu)
WO2009116089A2 (en) * 2008-03-14 2009-09-24 Ipca Laboratories Limited Novel intermediates and method for synthesis of 4'-[(1,4'-dimethyl-2'-propyl-[2,6'- bi-1hbenzimidazol]-l-yl)methyl]-1,1-biphenyl]-2-carboxylic acid.
EP2103588A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. 2'-Halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
US8410285B2 (en) 2008-03-20 2013-04-02 Lek Pharmaceuticals D.D. 2′-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
EP2103609A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. Catalyzed carbonylation in the synthesis of angiotensin ii antagonists
EP2123648A1 (en) 2008-05-20 2009-11-25 Chemo Ibérica, S.A. A process for the preparation of Telmisartan.
EP2149566A1 (en) 2008-07-15 2010-02-03 Chemo Ibérica, S.A. A process for the preparation of telmisartan
SI2443094T1 (sl) 2009-06-19 2013-08-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo telmisartana
EP2277866A1 (en) * 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
EP2305650A1 (en) 2009-09-21 2011-04-06 Chemo Ibérica, S.A. Novel process for the preparation of telmisartan
EA025946B1 (ru) 2010-10-27 2017-02-28 Крка, Товарна Здравил, Д. Д., Ново Место Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
CN102267949A (zh) * 2011-06-14 2011-12-07 张长利 替米沙坦制备新工艺
WO2014027280A1 (en) 2012-08-14 2014-02-20 U Amarnath Amarnath One pot process for the preparation of telmisartan
CN103787982A (zh) * 2012-10-31 2014-05-14 上海特化医药科技有限公司 制备替米沙坦的方法及其中间体
CN104557724B (zh) * 2014-11-17 2017-01-11 江苏中邦制药有限公司 替米沙坦不定形晶型及其制备方法
CN105130905B (zh) * 2015-09-17 2017-09-08 浙江金立源药业有限公司 一种替米沙坦的合成方法
CN109912512B (zh) * 2017-12-13 2023-05-30 上海科胜药物研发有限公司 一种新的替米沙坦杂质化合物及其制备方法和用途
CN112251770B (zh) * 2020-10-14 2021-07-27 湖南大学 一种抗高血压药替米沙坦中间体电化学制备新方法
CN113307775B (zh) * 2021-04-16 2022-04-22 河北戴桥医药科技有限公司 一种替米沙坦的制备方法
WO2023204729A1 (ru) * 2022-04-19 2023-10-26 Общество с ограниченной ответственностью "Гелеспон" Фармацевтические композиции на основе новой субстанции 4-[2-(1н-имидазол-4-ил)-этилкарбамоил]-бутановой кислоты и способ получения субстанции

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
DE4103492A1 (de) * 1991-02-06 1992-10-08 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5591762A (en) 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
DE19901921C2 (de) * 1999-01-19 2001-01-04 Boehringer Ingelheim Pharma Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels
US6358986B1 (en) 1999-01-19 2002-03-19 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan

Also Published As

Publication number Publication date
DE10314702A1 (de) 2004-10-21
ATE515500T1 (de) 2011-07-15
RU2430092C2 (ru) 2011-09-27
MXPA05009529A (es) 2005-10-19
US20040236113A1 (en) 2004-11-25
PT2322511E (pt) 2013-08-29
JP2006521289A (ja) 2006-09-21
SI1611108T1 (sl) 2011-10-28
CL2004000687A1 (es) 2005-02-04
NZ543244A (en) 2010-02-26
IL171145A (en) 2010-12-30
US8993778B2 (en) 2015-03-31
DK1611108T3 (da) 2011-10-10
EP1611108B1 (de) 2011-07-06
PL1611108T3 (pl) 2011-12-30
EP2322511A1 (de) 2011-05-18
CA2520714C (en) 2012-05-15
CY1115156T1 (el) 2016-12-14
WO2004087676A1 (de) 2004-10-14
AU2004226239A1 (en) 2004-10-14
CN1768044A (zh) 2006-05-03
PE20050390A1 (es) 2005-06-23
US20130137878A1 (en) 2013-05-30
SI2322511T1 (sl) 2013-10-30
DK2322511T3 (da) 2013-10-28
KR101096499B1 (ko) 2011-12-20
PL2322511T3 (pl) 2014-01-31
EP1611108A1 (de) 2006-01-04
UY28246A1 (es) 2004-11-08
KR20050118699A (ko) 2005-12-19
TW200504055A (en) 2005-02-01
BRPI0408861A (pt) 2006-04-11
PT1611108E (pt) 2011-09-01
CA2520714A1 (en) 2004-10-14
ES2369081T3 (es) 2011-11-25
TWI335916B (en) 2011-01-11
AU2004226239B2 (en) 2011-04-21
CN100418953C (zh) 2008-09-17
CY1112020T1 (el) 2015-11-04
JP5160740B2 (ja) 2013-03-13
AR043794A1 (es) 2005-08-10
US7193089B2 (en) 2007-03-20
EP2322511B1 (de) 2013-07-31
RU2005133479A (ru) 2006-07-27
ES2432647T3 (es) 2013-12-04

Similar Documents

Publication Publication Date Title
AR087209A2 (es) Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico
AR030947A1 (es) Guanidinas de acido cinamico substituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asi como un medicamento que las contiene
PE20091582A1 (es) Procedimiento para la preparacion de dihidropteridinonas
NZ600516A (en) Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
HK1073841A1 (en) Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
BRPI0516735B8 (pt) métodos para produção de (r)-2-acetamido-n-benzil-3-metoxipropionamida (lacosamida) e de uma formulação farmacêutica, e uso de (r)-n-benzil-2-nboc-amino-3-metoxipropionamida (c-937)
SV2004001373A (es) Inhibidores de pde9 para tratamiento de transtornos cardiovasculares. ref. pcs22051
DE60233420D1 (de) Fumagillolderivate und verfahren zu deren herstellung
CL2009001198A1 (es) Metodo para cuantificar una pluralidad de objetos rodantes sobre una correa transportadora, que comprende suministrar la pluralidad de objetos rodantes a una primera velocidad horizontal, operar la correa transportadora a una segunda velocidad horizontal, y cuantificar la pluralidad de objetos rodantes sobre la correa transportadora a una segunda velocidad horizontal; metodo para reducir el agrupamiento; ensamble.
GT200400165A (es) Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos
UY25980A1 (es) Polimorfos de telmisartan
BR112012013316A2 (pt) aditivo para agentes de ligação mineral tendo potencial reduzido de descoloração marrom
AR050709A1 (es) Metodo para preparar irbesartan e intermediarios del mismo
UY32243A (es) Proceso para la fabricacion de bromuros de 3-piridilmetil amonio sustituidos
BRPI0509988A (pt) processo para preparar ácido acrìlico por oxidação parcial heterogeneamente catalisada de pelo menos um composto precursor de hidrocarboneto c3
ITMI20022410A1 (it) Procedimento per la nitrazione di alcandioli.
BRPI0506690A (pt) processo para a preparação de 1,3-butileno glicol
PE20070809A1 (es) Composicion veterinaria que comprende closantel
AR051991A1 (es) Procedimiento para la preparacion de anilinas
AR047122A1 (es) Isomerizacion de compuestos de semicarbazona
PE20060951A1 (es) Proceso sintetico para la preparacion de compuestos aromaticos biciclicos
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
EA200201233A1 (ru) Способ получения бифенильных соединений
AR042194A1 (es) Metodo para preparar inhibidores de fosfodiesterasa - 4
AR033772A1 (es) Compuestos de 3-fenil-3,7-diazabiciclo[3,3,1]nonanto, asi como procedimientos para su preparacion y medicamentos que contienen estos compuestos

Legal Events

Date Code Title Description
FB Suspension of granting procedure